BrandImage+ has been prized with a Design Award at the prestigious Lisbon International Health Festival, a recognition accolade that evaluates health creativity from around the world.
The submitted award-winning project was the event brand identity of Sitagliptin’s 10 years in the Portuguese market, a MSD (Merck Sharp & Dohme) medication that has substantially increased diabetes patient’s quality of life.
The overall communication objective was accomplished: to reinforce the awareness of Sitagliptin’s social and health benefits among the medical community.
“As one of the most celebrated recognition programs for health advertising, it is truly an honor to win such a prominent award,” said José Horta Ferreira <https://www.linkedin.com/in/ACoAAAC96HABAdq9YYR8rs6q9Ygf_FxtIpVZm6Q/> Creative Director and CEO of BrandImage+.
Miguel Fragoso de Almeida <https://www.linkedin.com/in/ACoAAAN4rgYBAI9vLrxDFGwCGDesyYj5_y8BAZw/>, head of strategy at BrandImage+ mentioned “This award is a true testament to the hard work our team has put into the project. We are really pleased with the relationship developed with MSD and expect to celebrate further successes in Portugal and abroad in the years to come.”